Sanofi (SNY)

NasdaqGS • Currently down 0.16 (-0.40%) in today's trading session

5 members of Congress have disclosed 19 trades in Sanofi (SNY) via STOCK Act filings. The most recent disclosure was a sale by Lisa McClain on 11 September 2025. The most active traders have been John H. Rutherford (8), Lisa McClain (5), and Ro Khanna (2). Aggregate disclosed activity totals roughly $72K in purchases and $80K in sales (midpoint estimates from bracketed disclosure amounts).

Sanofi is currently trading at $40.07, positioned at 7% of its 52-week range ($39.18 – $52.68).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$40.07
24h Change
-0.16 (-0.40%)
52 Week Range
$39.18–$52.68
View on NASDAQ

Sanofi Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for SNY

Select to highlight on chart
5 transactions
Compliance: 58%
Lisa McClain11 Sept 202522 Oct 2025SaleStock$1,001 - $15,000N/A
Lisa McClain11 Sept 202513 Aug 2026SaleStock$1,001 - $15,000N/A
Lisa McClain4 Aug 202512 Sept 2025PurchaseStock$1,001 - $15,000N/A
Lisa McClain22 Jul 202513 Aug 2025SaleStock$1,001 - $15,000N/A
Lisa McClain17 Jun 202513 Aug 2025PurchaseStock$1,001 - $15,000N/A

See every trade

Sign in free to see the full trade history for this stock.

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$96.22B

Volume

2.1M

Beta

0.30

P/E Ratio

8.73

Fundamentals

EPS

$4.59

Div. Yield

6.04%

Open

$40.17

Day Range

$39.92 – $40.30

Company Information

Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NASDAQ · USD
Country
FR
CEO
Belén Garijo López
IPO Date
2002-07-01
Website
www.sanofi.com

Sanofi operates as a leading global pharmaceutical enterprise, dedicated to the research, development, production, and distribution of a wide array of therapeutic solutions across the United States, Europe, and numerous international markets. The com...

Earnings

Next Report

Q3 2026

30 Oct

EPS Est.

$1.72

Rev. Est.

$15.2B

Days Until

20

Recent Quarters

Q2 202630 Jul
EPS$1.21
Beat 10.0%
Q1 202623 Apr
EPS$1.10
Beat 3.8%
Q4 202529 Jan
EPS$0.89
Beat 6.0%
Q3 202524 Oct
EPS$1.70
Beat 6.3%
Q2 202531 Jul
EPS$0.90
Miss 6.3%
Q1 202524 Apr
EPS$0.94
Beat 4.4%
Q4 202430 Jan
EPS$0.70
Miss 1.4%
Q3 202425 Oct
EPS$1.57
Beat 16.3%
Q2 202425 Jul
EPS$0.93
Beat 8.1%
Q1 202425 Apr
EPS$0.97
Beat 3.2%
Q4 20231 Feb
EPS$0.89
Miss 5.3%
Q3 202327 Oct
EPS$1.39
Beat 1.5%
Q2 202328 Jul
EPS$0.95
Miss 38.7%
Q1 202327 Apr
EPS$1.16
Beat 5.5%
Q4 20223 Feb
EPS$0.87
Miss 3.3%
Q3 202228 Oct
EPS$1.44
Beat 7.5%
Q2 202228 Jul
EPS$0.92
Beat 5.8%
Q1 202228 Apr
EPS$1.09
Beat 16.0%
Q4 20214 Feb
EPS$0.79
Beat 9.7%
Q3 202128 Oct
EPS$1.29
Beat 9.3%
Q2 202129 Jul
EPS$0.83
Beat 10.7%
Q1 202128 Apr
EPS$0.97
Beat 16.9%
Q4 20205 Feb
EPS$0.73
Miss 17.1%
Q3 202029 Oct
EPS$1.07
Miss 0.9%
Q2 202029 Jul
EPS$0.65
Miss 7.1%
Q1 202024 Apr
EPS$0.90
Beat 18.4%
Q4 20196 Feb
EPS$0.74
Beat 5.7%
Q3 201931 Oct
EPS$1.07
Beat 11.5%
Q2 201929 Jul
EPS$0.74
Beat 10.4%
Q1 201926 Apr
EPS$0.81
Beat 8.0%
Q4 20187 Feb
EPS$0.63
Beat 1.6%
Q3 201831 Oct
EPS$1.07
Beat 9.2%
Q2 201831 Jul
EPS$0.74
Beat 2.8%
Q1 201827 Apr
EPS$0.79
Beat 6.8%
Q4 20177 Feb
EPS$0.62
Miss 10.1%
Q3 20172 Nov
EPS$1.00
Beat 0.0%
Q2 201731 Jul
EPS$0.74
Miss 2.6%
Q1 201728 Apr
EPS$0.76
Beat 4.1%
Q4 20168 Feb
EPS$0.67
Beat 1.5%
Q3 201628 Oct
EPS$1.00
Beat 16.3%
Q2 201629 Jul
EPS$0.74
Beat 2.8%
Q1 201629 Apr
EPS$0.74
Miss 3.9%
Q4 20159 Feb
EPS$0.72
Beat 4.3%
Q3 201529 Oct
EPS$0.89
Beat 1.1%
Q2 201530 Jul
EPS$0.78
Beat 8.3%
Q1 201530 Apr
EPS$0.73
Beat 19.7%
Q4 20145 Feb
EPS$0.79
Miss 11.2%
Q3 201428 Oct
EPS$0.94
Beat 0.0%
Q2 201431 Jul
EPS$0.72
Miss 8.9%
Q1 201429 Apr
EPS$0.81
Miss 3.6%
Q4 20136 Feb
EPS$0.93
Miss 27.3%
Q3 201330 Oct
EPS$0.93
Miss 8.8%
Q2 20131 Aug
EPS$0.73
Miss 18.0%
Q1 20132 May
EPS$0.80
Miss 10.1%
Q4 20127 Feb
EPS$0.78
Beat 1.3%
Q3 201225 Oct
EPS$1.05
Miss 45.3%
Q2 201230 Sept
EPS$1.50
Q4 201131 Mar
EPS$1.84
Q4 20118 Feb
EPS$1.05
Miss 34.0%
Q3 20113 Nov
EPS$1.26
Beat 4.1%
Q2 201130 Sept
EPS$2.04
Q4 201031 Mar
EPS$1.32
Q3 201031 Dec
EPS$0.24
Q2 201030 Sept
EPS$1.28
Q2 201029 Jul
EPS$0.85
Q1 201030 Jun
EPS$1.62
Q4 200910 Feb
EPS$1.01
Miss 51.0%
Q3 200931 Dec
EPS$1.33
Q1 200930 Jun
EPS$1.14
Q4 200831 Mar
EPS$1.62
Q4 200811 Feb
EPS$0.83
Miss 53.6%
Q3 200831 Dec
EPS$-1.69
Q1 200830 Jun
EPS$1.40
Q1 200830 Apr
EPS$1.06
Miss 80.4%
Q4 200712 Feb
EPS$0.79
Miss 1.3%
Q3 200731 Oct
EPS$0.94
Beat 10.6%
Q2 20071 Aug
EPS$0.84
Miss 5.6%
Q1 20073 May
EPS$1.03
Beat 18.4%
Q4 200613 Feb
EPS$0.66
Beat 11.9%
Q3 200631 Oct
EPS$0.80
Beat 12.7%
Q2 20062 Aug
EPS$0.84
Beat 7.7%
Q1 20065 May
EPS$0.97
Beat 10.2%
Q4 200524 Feb
EPS$0.64
Beat 1.6%
Q3 20058 Nov
EPS$0.88
Beat 20.6%
Q2 200531 Aug
EPS$0.73
Beat 7.3%
Q1 200513 May
EPS$0.70
Beat 7.7%
Q4 200431 Mar
EPS$1.37
Q2 200430 Sept
EPS$-4.20
Q1 200430 Jun
EPS$1.01
Q4 200331 Mar
EPS$0.94
Q3 200331 Dec
EPS$0.78
Q2 200330 Sept
EPS$1.08
Q1 200330 Jun
EPS$0.77
Q4 200231 Mar
EPS$0.72
Q3 200231 Dec
EPS$0.60
Q2 200230 Sept
EPS$0.63
Q1 200230 Jun
EPS$0.56

5 politicians traded within 30 days

Dividends

Dividend History

4 May 2026
Amount $2.4190
9 May 2025
Amount $2.1953
9 May 2024
Amount $2.0369
30 May 2023
Amount $1.9030
26 May 2022
Amount $0.2970
4 May 2022
Amount $1.7470
3 May 2021
Amount $1.9060
30 Apr 2020
Amount $1.7530
7 May 2019
Amount $1.7390
9 May 2018
Amount $1.8610
11 May 2017
Amount $1.5770
5 May 2016
Amount $1.6300
6 May 2015
Amount $1.6180
7 May 2014
Amount $1.9100
6 May 2013
Amount $1.8620
7 May 2012
Amount $1.7560
11 May 2011
Amount $1.8220
17 May 2010
Amount $1.6270
20 Apr 2009
Amount $1.4190
16 May 2008
Amount $1.5100
4 Jun 2007
Amount $1.1450
2 Jun 2006
Amount $0.9120
2 Jun 2005
Amount $0.7990
27 Sept 2004
Amount $0.0300
30 Apr 2004
Amount $0.5800
28 May 2003
Amount $0.4620

Stock Splits

Split History

30 Sept 2013Stock Split
Ratio5:1
17 Nov 2010Stock Split
Ratio10:1

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

CAH

Cardinal Health, Inc.

47
$237.57-1.39 (-0.58%)
Healthcare
Held by same politician
Same sector: Healthcare
1 politician
View Stock

THC

Tenet Healthcare Corporation

47
$263.78+3.21 (+1.23%)
Healthcare
Held by same politician
Same sector: Healthcare
1 politician
View Stock

NVDA

NVIDIA Corporation

17
$229.28-1.20 (-0.52%)
Technology
Held by same politician
1 politician
View Stock

Frequently Asked Questions about SNY

Which members of Congress have traded SNY?
5 members of Congress have disclosed 19 trades in Sanofi (SNY) under the STOCK Act. The most active traders are John H. Rutherford, Lisa McClain, and Ro Khanna.
When was SNY most recently disclosed by Congress?
The most recent SNY disclosure was a sale by Lisa McClain on 11 September 2025.
What is the total disclosed congressional trading volume for SNY?
Members of Congress have disclosed approximately $72K in SNY purchases and $80K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in SNY?
This SNY page updates as soon as new STOCK Act disclosures are filed for Sanofi. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.